about
Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery DiseaseNational trends in the treatment of diabetic nephropathy in the United States.Diabetic Nephropathy: a Tangled Web to Unweave.Defining Phenotypes in Diabetic Nephropathy: a novel approach using a cross-sectional analysis of a single centre cohort.Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Diabetic nephropathy: What does the future hold?
@ast
Diabetic nephropathy: What does the future hold?
@en
type
label
Diabetic nephropathy: What does the future hold?
@ast
Diabetic nephropathy: What does the future hold?
@en
prefLabel
Diabetic nephropathy: What does the future hold?
@ast
Diabetic nephropathy: What does the future hold?
@en
P2093
P2860
P1476
Diabetic nephropathy: What does the future hold?
@en
P2093
P2860
P304
P356
10.1007/S11255-015-1121-Y
P577
2015-10-05T00:00:00Z
2016-01-01T00:00:00Z